Literature DB >> 953914

Cholera: synopsis of clinical aspects and principles of treatment.

W H Frost.   

Abstract

Cholera varies greatly in clinical severity; the mortality of untreated severe cholera may be as high as 60% The main clinical feature is dehydration; fluid lost in the stools may amount to 60/. Rehydration is the cornerstone of treatment. The amount of fluid required is approximately 10% of body weight in severe dehydration and 5 to 8% in moderate dehydration. Fluid therapy, which must be individualized, may be successful on its own, but chemo-therapy shortens the duration of illness. Tetracycline (in adults, 40 mg/kg for 2 days; in children, 50 mg/kg for 2 days) reduces the fluid loss and eliminates the causative organisms. Vaccination is of limited value.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953914      PMCID: PMC1878711     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  NON-VIBRIO CHOLERA.

Authors:  J LINDENBAUM; W B GREENOUGH; A S BENENSON; R OSEASOHN; S RIZVI; A SAAD
Journal:  Lancet       Date:  1965-05-22       Impact factor: 79.321

2.  Cholera in pregnant women.

Authors:  N Hirschhorn; A K Chowdhury; J Lindenbaum
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321

Review 3.  Cholera: diagnosis and treatment.

Authors:  C C Carpenter
Journal:  Bull N Y Acad Med       Date:  1971-10

4.  Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae.

Authors:  R B Sack; C E Miller
Journal:  J Bacteriol       Date:  1969-09       Impact factor: 3.490

  4 in total
  1 in total

1.  Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species.

Authors:  Erika Acosta-Smith; Karina Viveros-Jiménez; Adrian Canizalez-Román; Magda Reyes-Lopez; Jan G M Bolscher; Kamran Nazmi; Hector Flores-Villaseñor; Gerardo Alapizco-Castro; Mireya de la Garza; Jesús J Martínez-Garcia; Jorge Velazquez-Roman; Nidia Leon-Sicairos
Journal:  Front Microbiol       Date:  2018-01-11       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.